Skip to main content
Premium Trial:

Request an Annual Quote

Devgen Awarded 1.9M Euro From Flemish Government

NEW YORK, Nov. 20 (GenomeWeb News) - Devgen has been awarded a grant for 1.9 million Euro ($2.3 million) from the Flemish Government in Flanders, Belgium to develop the company's C. elegans RNAi and genetics technology for identification of mechanism of action in human drugs, the company said today.


The Flemish Institute for the Promotion of Industrial Scientific and Technological Research has awarded the grant, the company said.


Devgen's technology uses RNAi to identify functionally validated genes in the model organism C. elegans. The company has in-house programs to develop therapies for metabolic and cardiovascular diseases, as well as development of nematode- and insect-resistant crops and novel pesticides.

The Scan

Back as Director

A court has reinstated Nicole Boivin as director of the Max Planck Institute for the Science of Human History, Science reports.

Research, But Implementation?

Francis Collins reflects on his years as the director of the US National Institutes of Health with NPR.

For the False Negatives

The Guardian writes that the UK Health Security Agency is considering legal action against the lab that reported thousands of false negative COVID-19 test results.

Genome Biology Papers Present Epigenetics Benchmarking Resource, Genomic Architecture Maps of Peanuts, More

In Genome Biology this week: DNA methylation data for seven reference cell lines, three-dimensional genome architecture maps of peanut lines, and more.